readthroughSign in
Aug 7, 2026Financing

Shiverbright Technologies files Form D for SAFE offering, first sale dated July 31, 2026

The Delaware biotech reported one investor and $200,000 raised through a Simple Agreement for Future Equity, in a notice signed August 7, 2026.

Shiverbright Technologies, Inc., a Delaware corporation based in Lafayette, Colorado, filed a Form D with the Securities and Exchange Commission disclosing an exempt securities offering. The filing is a new notice with a date of first sale listed as 2026-07-31.1 The notice itself was signed and submitted on August 7, 2026, by CEO Logan Thrasher Collins.1

The company classified itself under the biotechnology industry group within health care.1 Shiverbright reported no revenues at the time of filing.1

The security type offered was described as a Simple Agreement for Future Equity (SAFE), listed under the "Other" category of securities offered.1 The offering claims exemption under Rule 506(b) of Regulation D.1 The issuer indicated the offering is not intended to last more than one year.1

On amounts, the total offering amount was listed as indefinite, while the total amount sold was reported as $200,000, with the remaining amount to be sold also listed as indefinite.1 The filing states one investor has already invested in the offering.1 The minimum investment accepted from any outside investor was listed as $0.1

No sales commissions or finder's fees were reported. Sales commissions and finders' fees were both listed as $0.1 The company estimated $10,000 in gross proceeds would go toward payments to persons named as executive officers, directors, or promoters.1 The offering was not described as being made in connection with a business combination transaction such as a merger or acquisition.1

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.